Continuous s.c. infusion rather than twice-daily injections of IGF-I more effectively increases serum IGF binding protein-3 in female monkeys

European Journal of Endocrinology

Volumn 141, Issue 3, 1999, Pages 303-312

  Wilson, M E ^a   Lackey, S L ^a  

^a EMORY UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE; INSULIN; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; FEMALE; FOOD INTAKE; HORMONAL REGULATION; HORMONE BLOOD LEVEL; INSULIN BLOOD LEVEL; MONKEY; NONHUMAN; PRIORITY JOURNAL; REGULATORY MECHANISM;

ANIMALS; BLOOD GLUCOSE; CHEMILUMINESCENT MEASUREMENTS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; COLORIMETRY; ELECTROPHORESIS, POLYACRYLAMIDE GEL; FEMALE; IMMUNORADIOMETRIC ASSAY; INFUSION PUMPS, IMPLANTABLE; INFUSIONS, PARENTERAL; INJECTIONS, INTRAVENOUS; INSULIN; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 1; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; INSULIN-LIKE GROWTH FACTOR I; MACACA MULATTA; RADIOIMMUNOASSAY; RANDOM ALLOCATION;

EID: 0032848217     PISSN: 08044643     EISSN: None     Source Type: Journal    
DOI: 10.1530/eje.0.1410303     Document Type: Article

References (45)

1. Lewitt MS. Role of insulin-like growth factors in the endocrine control of glucose homeostasis. Diabetes Research in Clinical Practice 1994 23 3-15.
2. Baxter RC, Dai J, Holman S & Lewitt MS. Determinants of complex formation between insulin-like growth factor binding protein-3 and the acid labile subunit. In The Insulin-Like Growth Factors And Their Regulatory Proteins, pp 227-235. Eds RC Baxter, PD Gluckman & RG Rosenfeld. Amsterdam: Elsevier, 1994.
3. Savage MO, Blum WF, Ranke MB, Postel-Vinay MC, Cotterill AM, Hall K, Chatelain PG, Preece MA & Rosenfeld RG. Clinical features and endocrine status in patients with growth hormone receptor deficiency. Journal of Clinical Endocrinology and Metabolism 1993 77 1465-1471.
4. Blum WF, Albertsson-Wikland K, Rosberg S & Ranke M. Serum levels of insulin-like growth (IGF)-I and IGF binding protein-3 reflect spontaneous GH secretion. Journal of Clinical Endocrinology and Metabolism 1993 76 1610-1616.
5. Nilsson A, Carlsson B, Isgaard J, Isaksson OGP & Rymo L. Regulation by growth hormone of insulin-like growth factor-I mRNA expression in rat epiphyseal growth plate as studied by in situ hybridization. Journal of Endocrinology 1990 125 67-74.
6. Gosteli-Peter MA, Winterhalter KH, Schmid C, Froesch ER & Zapf J. Expression and regulation of insulin-like growth factor (IGF)-I and IGF binding protein-3 mRNA in tissues of hypophysectomized rats infused with IGF-I and growth hormone. Endocrinology 1994 135 2558-2567.
7. Zapf J. Physiological role of the insulin-like growth factor binding proteins. European Journal of Endocrinology 1995 132 645-654.
8. Gargosky SE, Tapanainen P & Rosenfeld RG. Administration of growth hormone but not insulin-like growth factor (IGF)-I by continuous infusion can induce formation of the 150kDa IGF binding protein-3 complex in growth hormone deficient rats. Endocrinology 1994 134 2267-2276.
9. Villafuerte BC, Zhang WN & Phillips LS. Insulin and insulin-like growth factor-I regulate hepatic insulin-like growth factor binding protein-3 by different mechanisms. Molecular Endocrinology 1996 10 622-630.
10. Kanety H, Karasik A, Klinger B, Silbergeld A & Laron Z. Long-term treatment of Laron type dwarfs with insulin-like growth factor-I increases serum insulin-like growth factor binding protein-3 in absence of GH activity. Acta Endocrinologica 1993 128 144-149.
11. Kanety H, Silbergeld, Klinger B, Karasik A, Baxter RC & Laron Z. Long-term effects of insulin-like growth factor (IGF)-I on serum IGF-I, IGF-binding protein-3 and acid labile subunit in Laron syndrome patients with normal growth hormone binding protein. European Journal of Endocrinology 1997 137 626-630.
12. Hasegawa Y, Hasegawa T, Fujii K, Konii H, Anzo M, Aso T, Kotoh S & Tsuchiya Y. Clinical information on serum IGFBP-3 levels and IGFBP-3 proteolytic activity in childhood. Progress in Growth Factor Research 1995 6 457-463.
13. Gargosky SE, Wilson KF, Fielder PJ, Vaccarello MA, Guevara-Aguirre J, Diamond FB, Baxter RC, Rosenbloom AL & Rosenfeld RG. The composition and distribution of insulin-like growth factors (IGFs) and IGF binding proteins (IGFBPs) in serum of growth hormone receptor deficient patients: effects of IGF-I therapy on IGFBP-3. Journal of Clinical Endocrinology and Metabolism 1993 77 1683-1689.
14. Wilson KF, Fielder PJ, Guevara-Aguirre J, Cohen P, Vasconez O, Martinez V, Martinez A, Rosenbloom AL & Rosenfeld RG. Long-term effects of insulin-like growth factor-I (IGF-I) treatment on serum IGF-I and IGF binding proteins in adolescent patients with growth hormone receptor deficiency. Clinical Endocrinology 1995 42 399-407.
15. Ranke MB, Savage MO, Chatelain PG, Preece MA, Rosenfeld RG, Blum WF & Wilton P. Insulin-like growth factor-I improves height in GH insensitivity. Hormone Research 1995 44 253-264.
16. Guevara-Aguirre J, Vasconez O, Martinez V, Martinez A, Rosenbloom AL, Diamond FB, Gargosky SE, Nonoshita L & Rosenfeld RG. A randomized, double blind, placebo-controlled trial on safety and efficacy of insulin-like growth factor-I in children with growth hormone receptor deficiency. Journal of Clinical Endocrinology and Metabolism 1995 80 1392-1398.
17. Baxter RC, Hizuka N, Takano K, Holman SR & Asakawa K. Responses of insulin-like growth factor binding protein-1 and insulin-like growth factor binding protein-3 complex to administration of insulin-like growth factor-I. Acta Endocrinologica 1993 128 101-108.
18. Kupfer SR, Underwood LE, Baxter RC & Clemmons DR Enhancement of the anabolic effects of growth hormone and insulin-like growth factor I by use of both agents simultaneously. Journal of Clinical Investigation 1993 91 391-396.
19. Bach MA, Chin E & Bondy CA. The effects of subcutaneous insulin-like growth factor-I infusion in insulin-dependent diabetes mellitus. Journal of Clinical Endocrinology and Metabolism 1994 79 1040-1045.
20. Binoux M. GH, IGFs, IGF-binding protein-3 and acid-labile subunit: what is the pecking order? European Journal of Endocrinology 1997 137 605-609.
21. Wilson ME. Administration of insulin-like growth factor-I affects the growth hormone axis and adolescent growth in normal monkeys. Journal of Endocrinology 1997 153 327-335.
22. Wilson ME. Regulation of the growth hormone-insulin-like growth factor-I axis in developing and adult monkeys is affected by estradiol replacement and supplementation with insulin-like growth factor-I. Journal of Clinical Endocrinology and Metabolism 1998 83 2018-2028.
23. Lewitt MS, Denyer GS, Cooney GJ & Baxter RC. Insulin-like growth factor binding protein-1 modulates blood glucose levels. Endocrinology 1991 129 2254-2256.
24. Nyomba BL, Rerard L & Murphy LJ. Free insulin-like growth factor-I in healthy subjects: relationship with insulin-like growth factor binding proteins and insulin sensitivity. Journal of Clinical Endocrinology and Metabolism 1997 82 2177-2181.
25. Lee PDK, Giudice LC, Conover CA & Powell DR. Insulin-like growth factor binding protein-1: recent findings and new directions. Proceedings of the Society for Experimental Biology and Medicine 1997 216 319-357.
26. Rutanen EM. Insulin-like growth factor binding protein-1. Seminars in Reproductive Endocrinology 1992 2 154-163.
27. Wilson ME. Insulin-like growth factor-I administration advances the decrease in hypersensitivity to estradiol negative feedback inhibition of serum LH in adolescent female rhesus monkeys. Journal of Endocrinology 1995 145 121-130.
28. Walker ML, Gordon TP & Wilson ME. Reproductive performance of capture-acclimated female rhesus monkeys. Journal of Medical Primatology 1982 11 291-302.
29. Blank MS, Gordon TP & Wilson ME. Effects of capture and venipuncture on serum levels of prolactin, growth hormone and cortisol in outdoor compound-housed female rhesus monkeys. Acta Endocrinologica 1983 102 190-195.
30. Guevara-Aguirre J, Rosenbloom AL, Vasconez O, Marinez V, Gargosky SE, Allen L & Rosenfeld RG. Two-year treatment of growth hormone (GH) receptor deficiency with recombinant insulin-like growth factor I in 22 children: comparison of two dosage levels and to GH-treated GH deficiency. Journal of Clinical Endocrinology and Metabolism 1997 82 629-633.
31. Osterud EL, Lackey S & Wilson ME. Estradiol increases somatomedin-C concentrations in adolescent rhesus monkeys. American Journal of Primatology 1986 11 53-62.
32. Op De Beeck L, Verlooy JEA, Van Buul-Offers SC & Du Caju MVL. Detection of serum insulin-like growth factor binding proteins on Western ligand blots by biotinylated IGF and enhanced chemiluminescence. Journal of Endocrinology 1997 154 R1-R5.
33. Schneiderman R, Rosenberg N, Hiss J, Lee P, Liu F, Hintz RL & Maroudas A. Concentration and size distribution of insulin-like growth factor-I in human normal and osteoarthritic synovial fluid and cartilage. Archives of Biochemistry and Biophysics 1995 324 173-188.
34. Bale LK & Conover CA. Regulation of insulin-like growth factor binding protein-3 messenger ribonucleic acid expression by insulin-like growth factor I. Endocrinology 1992 131 608-614.
35. Wilson ME. Premature elevation in serum insulin-like growth factor-I advances first ovulation in rhesus monkeys. Journal of Endocrinology 1998 158 247-257.
36. Wilson ME. IGF-I administration advances the decrease in hypersensitivity to oestradiol negative feedback inhibition of serum LH in adolescent female rhesus monkeys. Journal of Endocrinology 1995 145 121-130.
37. Scharf JG, Schmidt-Sandte W, Pahernik A, Koebe HG & Hartman H. Synthesis of insulin-like growth factor binding proteins and the acid labile subunit of the insulin-like growth factor ternary binding protein complex in primary cultures of human hepatocytes. Journal of Hepatology 1995 23 424-430.
38. Wilson ME. Effects of estradiol and exogenous insulin-like growth factor (IGF)-I on the IGF-I axis during GH inhibition and antagonism. Journal of Clinical Endocrinology and Metabolism 1998 83 4013-4021.
39. Wilson ME. IGF-I but not the variant IGF-I analog increases serum IGF binding protein-3 in adolescent female monkeys. Growth Hormone and IGF Research 1998 8 315.
40. Fielder PJ, Mortensen DL, Mallet P, Carlsson B, Baxter RC & Clark RG. Differential long-term effects of insulin-like growth factor-I (IGF-I), growth hormone (GH), and IGF-I plus GH on body growth and IGF binding proteins in hypophysectomized rats. Endocrinology 1996 137 1913-1920.
41. Cotterill AM, Holly JM, Amiel S & Wass JAH. Suppression of endogenous insulin secretion regulates the rapid rise of insulin-like growth factor binding protein (IGFBP)-1 levels following acute hypoglycemia. Clinical Endocrinology 1993 38 633-639.
42. Hardouin S, Gourmelen M, Noguiez P, Seurin D, Goghani M, Bouc YL, Povoa G, Merimee TJ, Hossenlopp P & Binoux M. Molecular forms of serum insulin-like growth factor (IGF)-binding proteins in man: relationships with growth hormone and IGFs and physiological significance. Journal of Clinical Endocrinology and Metabolism 1989 69 1291-1301.
43. Lindgren BF, Segovia B, LaSarre C & Binoux M. Growth retardation in constitutionally short children is related to low serum insulin-like growth factor-I and its reduced bioavailability. Growth Regulation 1996 6 158-164
44. Cotterill AM, Camacho-Hubner C, Holly LMP & Savage MO. The effect of recombinant human insulin-like growth factor-I treatment on growth hormone secretion in two subjects with growth hormone insensitivity (Laron syndrome). Clinical Endocrinology 1993 39 119-122.
45. Cox GN, McDermott MJ, Merkel E, Stroh CA, Ko SC, Squires CH, Gleason TM & Russell D. Recombinant human insulin-like growth factor binding protein-1 inhibits somatic growth stimulated by insulin-like growth factor-I and growth hormone in hypophysectomized rats. Endocrinology 1994 135 1913-1920.